Centiva Capital, LP Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $1.5 Million - $2.59 Million	10,500 New	10,500 $2.55 Million
Q2 2022 Aug 17, 2022	BUY	$120.42 - $169.29 $144,504 - $203,148	1,200 New	1,200 $175,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $342,441 - $474,363	-2,700 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $55,872 - $80,394	-600 Reduced 18.18%	2,700 $293,000
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $233,970 - $289,806	3,300 New	3,300 $265,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.